论文部分内容阅读
我院从1966年至1984年共收治100例眼睑癌。单纯放疗82例,术后放疗17例,术前后放疗1例。照射采用120～180KV-X线,SSD30～40cm,半价层0.5～0.95mm Cu。术前29例快速照射30～42.5Gy/4～5次,共5～10天。53例常规照射50～60Gy/20～30次,24～36天。术后放疗30～60Gy,5～30次,共6～48天,全组5年生存率为87％(87/100)。综合组和单纯放疗生存无差异。T_4患者较T_(1-3)生存率低,但无统计差异,死亡原因主要为局部复发和远地转移。
In our hospital, 100 cases of orbital cancer were treated from 1966 to 1984. There were 82 cases of radiotherapy alone, 17 cases of postoperative radiotherapy, and 1 case of preoperative and postoperative radiotherapy. Irradiation uses 120 to 180 KV-X rays, SSD 30 to 40 cm, half-price layer 0.5 to 0.95 mm Cu. Preoperative exposure to rapid irradiation of 30 to 42.5Gy/4 to 5 times for 5 to 10 days. 53 cases of conventional irradiation 50 ~ 60Gy/20 ~ 30 times, 24 ~ 36 days. Postoperative radiotherapy 30 ~ 60Gy, 5 ~ 30 times, a total of 6 to 48 days, the whole group 5-year survival rate was 87% (87/100). There was no difference in survival between the comprehensive group and radiotherapy alone. The survival rate of T_4 patients was lower than T_(1-3), but there was no statistical difference. The main cause of death was local recurrence and distant metastasis.